Order by 12pm AEDT, Monday to Friday, for same-day shipping!

Sarm Nation
Sarm Nation
Sarm Nation
PT-141

PT-141

$110.00

48 in stock (can be backordered)

By Buying 

3 Bottles

You can get 10% off

By Buying 

6 Bottles

You can get 15% off

By Buying 

9 Bottles

You can get 20% off

To get a discount, simply add products to the cart and continue to the checkout page, and the discount will automatically be applied.

PT-141 Peptide: Melanocortin Receptor Agonist for Sexual Function Research

PT-141, also known as Bremelanotide, is a synthetic peptide derived from α-melanocyte-stimulating hormone (α-MSH) and studied for its effects on sexual arousal, desire, and central nervous system signalling. Unlike phosphodiesterase inhibitors, PT-141 acts primarily through the central melanocortin receptor system, rather than directly affecting peripheral blood flow. PT-141 has been investigated in both male and female research models for conditions involving hypoactive sexual desire, erectile dysfunction, and altered sexual motivation. Its mechanism involves activation of melanocortin receptors (MC3R and MC4R) in the brain, which are associated with sexual behaviour, mood, and reward pathways. Due to this central mode of action, PT-141 is often studied as a distinct alternative to vasodilatory compounds in sexual health research.

Product Summary Table

Peptide Name PT-141 (Bremelanotide)
Peptide Class Melanocortin receptor agonist
Primary Targets MC3R and MC4R receptors
Mechanism of Action Central nervous system melanocortin signalling
Form Lyophilised synthetic peptide (must be reconstituted)
Research Vial Format 10 mg
Country of Origin Australia
Storage Lyophilised: store cold and protected from light; Reconstituted: 2–8°C
Standard Research Grade Purity ≥98 percent

In Vivo Research Benefits

PT-141 has been evaluated in controlled clinical and preclinical studies examining sexual function and neurobehavioural responses.
  • Increased sexual arousal observed in both male and female research participants.
  • Central modulation of sexual desire independent of nitric oxide pathways.
  • Improved erectile response in male models through CNS-mediated signalling.
  • Enhanced sexual motivation linked to melanocortin receptor activation.
  • Distinct mechanism compared to PDE5 inhibitors such as sildenafil.

Benefits of PT-141 Peptide

  • Central Nervous System Action targeting sexual desire pathways.
  • Applicable to Both Sexes in sexual function research models.
  • Non-Vasodilatory Mechanism unlike traditional erectile dysfunction agents.
  • Well Studied Melanocortin Pathway with human clinical trial data.
  • Unique Peptide Profile for sexual health and behavioural research.

Studies and Additional Info

  • Clinical trials investigating PT-141 in hypoactive sexual desire disorder
  • Research on melanocortin receptor signalling and sexual behaviour
  • Comparative studies versus PDE5 inhibitors
  • Neuroendocrine and CNS pathway analyses involving α-MSH derivatives
Disclaimer: PT-141 is supplied strictly for laboratory research purposes. It is not intended for human consumption or therapeutic use.

Frequently Asked Questions

What is PT-141 studied for?

PT-141 is studied for sexual arousal, libido regulation, and central nervous system signalling related to sexual behaviour.

How does PT-141 differ from Viagra or Cialis?

PT-141 acts centrally through melanocortin receptors in the brain, while PDE5 inhibitors act peripherally by increasing blood flow.

Is PT-141 studied in both men and women?

Yes. Research includes both male and female models, particularly in studies of sexual desire and arousal.

Does PT-141 affect blood pressure?

Some studies report transient effects such as nausea or changes in blood pressure, which are monitored in clinical research settings.

Is PT-141 approved for general human use?

No. PT-141 is supplied for research purposes only and is not approved for general human consumption.

    Which product’s lab result would you like to receive?

    Our RAD140 3rd party lab test will be emailed to you once submitted.

    Our RAD150 3rd party lab test will be emailed to you once submitted.

    Our MK677 3rd party lab test will be emailed to you once submitted.

    Our MK2866 3rd party lab test will be emailed to you once submitted.

    Our SR9009 3rd party lab test will be emailed to you once submitted.

    Our LGD4033 3rd party lab test will be emailed to you once submitted.

    Our S4 3rd party lab test will be emailed to you once submitted.

    Our S23 3rd party lab test will be emailed to you once submitted.

    Our GW0742 3rd party lab test will be emailed to you once submitted.

    Our GW501516 3rd party lab test will be emailed to you once submitted.

    Our YK11 3rd party lab test will be emailed to you once submitted.

    Our GHRP-2 3rd party lab test will be emailed to you once submitted.

    Our CJC-1295 with DAC 3rd party lab test will be emailed to you once submitted.

    Our TB-500 3rd party lab test will be emailed to you once submitted.

    Our BPC-157 3rd party lab test will be emailed to you once submitted.

    Our GHRP-6 3rd party lab test will be emailed to you once submitted.

    Our HGH 12IU 3rd party lab test will be emailed to you once submitted.

    Our HCG 3rd party lab test will be emailed to you once submitted.

    Our PT-141 3rd party lab test will be emailed to you once submitted.

    Our SHK-CU 3rd party lab test will be emailed to you once submitted.

    Our Ipamorelin 3rd party lab test will be emailed to you once submitted.

    Our Retatutide 3rd party lab test will be emailed to you once submitted.

    Our Tizepatide 3rd party lab test will be emailed to you once submitted.

    Our MELANOTAN II 3rd party lab test will be emailed to you once submitted.

    Our Tesamorelin 3rd party lab test will be emailed to you once submitted.

    Our MOTS-c 3rd party lab test will be emailed to you once submitted.

    This is a test group.

    Description

    PT-141 Peptide: Melanocortin Receptor Agonist for Sexual Function Research

    PT-141, also known as Bremelanotide, is a synthetic peptide derived from α-melanocyte-stimulating hormone (α-MSH) and studied for its effects on sexual arousal, desire, and central nervous system signalling. Unlike phosphodiesterase inhibitors, PT-141 acts primarily through the central melanocortin receptor system, rather than directly affecting peripheral blood flow. PT-141 has been investigated in both male and female research models for conditions involving hypoactive sexual desire, erectile dysfunction, and altered sexual motivation. Its mechanism involves activation of melanocortin receptors (MC3R and MC4R) in the brain, which are associated with sexual behaviour, mood, and reward pathways. Due to this central mode of action, PT-141 is often studied as a distinct alternative to vasodilatory compounds in sexual health research.

    Product Summary Table

    Peptide Name PT-141 (Bremelanotide)
    Peptide Class Melanocortin receptor agonist
    Primary Targets MC3R and MC4R receptors
    Mechanism of Action Central nervous system melanocortin signalling
    Form Lyophilised synthetic peptide (must be reconstituted)
    Research Vial Format 10 mg
    Country of Origin Australia
    Storage Lyophilised: store cold and protected from light; Reconstituted: 2–8°C
    Standard Research Grade Purity ≥98 percent

    In Vivo Research Benefits

    PT-141 has been evaluated in controlled clinical and preclinical studies examining sexual function and neurobehavioural responses.

    • Increased sexual arousal observed in both male and female research participants.
    • Central modulation of sexual desire independent of nitric oxide pathways.
    • Improved erectile response in male models through CNS-mediated signalling.
    • Enhanced sexual motivation linked to melanocortin receptor activation.
    • Distinct mechanism compared to PDE5 inhibitors such as sildenafil.

    Benefits of PT-141 Peptide

    • Central Nervous System Action targeting sexual desire pathways.
    • Applicable to Both Sexes in sexual function research models.
    • Non-Vasodilatory Mechanism unlike traditional erectile dysfunction agents.
    • Well Studied Melanocortin Pathway with human clinical trial data.
    • Unique Peptide Profile for sexual health and behavioural research.

    Studies and Additional Info

    • Clinical trials investigating PT-141 in hypoactive sexual desire disorder
    • Research on melanocortin receptor signalling and sexual behaviour
    • Comparative studies versus PDE5 inhibitors
    • Neuroendocrine and CNS pathway analyses involving α-MSH derivatives

    Disclaimer: PT-141 is supplied strictly for laboratory research purposes. It is not intended for human consumption or therapeutic use.

    Frequently Asked Questions

    What is PT-141 studied for?

    PT-141 is studied for sexual arousal, libido regulation, and central nervous system signalling related to sexual behaviour.

    How does PT-141 differ from Viagra or Cialis?

    PT-141 acts centrally through melanocortin receptors in the brain, while PDE5 inhibitors act peripherally by increasing blood flow.

    Is PT-141 studied in both men and women?

    Yes. Research includes both male and female models, particularly in studies of sexual desire and arousal.

    Does PT-141 affect blood pressure?

    Some studies report transient effects such as nausea or changes in blood pressure, which are monitored in clinical research settings.

    Is PT-141 approved for general human use?

    No. PT-141 is supplied for research purposes only and is not approved for general human consumption.

    Additional information

    Weight 0.02 kg

    Related products

    Sarm Nation

    Copyright © 2025 Sarm Nation. All rights reserved